Study #2020-0989
Clinicopathologic and Ancillary Testing of Primary Clear Cell Carcinoma of the Cervix-A Rare Tumor
MD Anderson Study Status
Enrolling
Treatment Agent
Description
This study aims to provide a comprehensive report on clinicopathologic features, immunohistochemical/biomarker testing and molecular profile of cervical clear cell carcinoma. This study may help researchers learn more about the molecular profile of cervical clear cell carcinoma.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Human Papillomavirus-Independent Cervical Adenocarcinoma, Clear Cell-Type
Study phase:
Physician name:
Anais Malpica
Department:
Pathology
For general questions about clinical trials:
1-877-581-3446
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.